Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04206436 · ClinicalTrials.gov registry record
CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis
A clinical trial of Cystic Fibrosis and Bone Loss, sponsored by Indiana University.
- Active
- Registry status
- 63
- Enrollment target
- 1
- Study location
NCT04206436 is a study of Cystic Fibrosis and Bone Loss that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 63 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04206436, a study of Cystic Fibrosis and Bone Loss, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
Study is looking at the effects of cystic fibrosis treatment on bone muscle.
Conditions Studied
Interventions
- DRUG Cftr Modulators
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2019-12-18 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04206436
The ClinicalTrials.gov registry entry for NCT04206436 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (65% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Cftr Modulators is the first listed.
NCT04206436 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT04206436 about?
NCT04206436 is a clinical study titled "CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis". Study is looking at the effects of cystic fibrosis treatment on bone muscle.
What is the current status of trial NCT04206436?
This trial is currently active not recruiting. The enrollment target is 63 participants. The study started on 2019-12-18. Estimated completion is 2027-12-31.
What conditions does trial NCT04206436 study?
This clinical trial studies the following conditions: Cystic Fibrosis, Bone Loss, Muscle Loss.
What interventions are being tested in trial NCT04206436?
The interventions under investigation include: Cftr Modulators (DRUG).
Who is sponsoring clinical trial NCT04206436?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04206436 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RECRUITING
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Genetics of Insulin and Incretins in Cystic Fibrosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.